Dry Eye Syndrome Market Size Worth USD 10.55 Billion in 2032 | Emergen Research
10 janv. 2024 07h38 HE
|
Emergen Research
Vancouver, Jan. 10, 2024 (GLOBE NEWSWIRE) -- The global dry eye syndrome market size was USD 5.32 billion in 2022 and is expected to register a revenue CAGR of 7.3% during the forecast period....
Dry Eye Syndrome Market revenue to cross USD 600 Million by 2035, says Research Nester
10 juil. 2023 06h50 HE
|
Research Nester
New York, July 10, 2023 (GLOBE NEWSWIRE) -- The global dry eye syndrome market is estimated to grow at a CAGR of ~8% from 2023 to 2035. The market is estimated to garner a revenue of ~USD 600...
Worldwide Demand for Dry Eye Syndrome Treatment Market Will Surge at 7.0% CAGR from 2022 to 2032 | Future Market Insights, Inc.
02 mars 2023 20h30 HE
|
Future Market Insights Global and Consulting Pvt. Ltd.
DUBAI, United Arab Emirates, March 02, 2023 (GLOBE NEWSWIRE) -- The global dry eye syndrome treatment market is anticipated to exceed a value of US$ 8.84 billion by 2032, with sales growing at a...
OTC Artificial Tears Market Size is projected to reach USD 6.79 Billion by 2030, growing at a CAGR of 5.10%: Straits Research
18 août 2022 10h30 HE
|
Straits Research
New York, United States, Aug. 18, 2022 (GLOBE NEWSWIRE) -- The application of artificial tears protects and hydrates mucous membranes and alleviates dryness and irritation of the eyes. Artificial...
I-Med Pharma USA Partners With DryEye Rescue to Distribute Its Innovative Dry Eye Product Portfolio in the United States
03 févr. 2022 11h00 HE
|
I-MED Pharma
MONTREAL, Feb. 03, 2022 (GLOBE NEWSWIRE) -- With the recent launch of its line of dry eye diagnostics, management, and treatment solutions into the United States, I-MED Pharma USA has partnered with...
NTC and I-MED Pharma form strategic partnership to bring the leading HA-based dry eye ointment to the United States market
15 déc. 2021 07h00 HE
|
I-MED Pharma
MONTREAL, Dec. 15, 2021 (GLOBE NEWSWIRE) -- NTC Srl, R&D driven pharmaceutical company with headquarters in Italy, and I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and...
I-MED Pharma USA Announces Michelle Schnabel as VP Business Development
09 nov. 2021 11h00 HE
|
I-MED Pharma
MONTREAL, Nov. 09, 2021 (GLOBE NEWSWIRE) -- With the recent expansion into the United States, I-MED Pharma USA is proud to announce the appointment of Michelle Schnabel to the role of VP Business...
Dry Eye Syndrome Market to Reach USD 6.54 Billion by 2027 | Market Size, Share, Growth, Revenue, Competitive Landscape, Forecasts, & Trends Analysis Report with COVID-19 Impact by Fortune Business Insights™
09 nov. 2021 05h12 HE
|
Fortune Business Insights
Pune, India, Nov. 09, 2021 (GLOBE NEWSWIRE) -- The global dry eye syndrome market size is expected to reach USD 6.54 billion by 2027, exhibiting a CAGR of 4.7% during the forecast period. The...
I-MED Pharma USA Announces Brent Jones as Chief Commercial Officer
08 nov. 2021 11h00 HE
|
I-MED Pharma
MONTREAL, Nov. 08, 2021 (GLOBE NEWSWIRE) -- With the recent expansion into the United States, I-MED Pharma USA is proud to announce the appointment of Brent Jones to Chief Commercial Officer...
I-MED Pharma Set to Launch Its Innovative Dry Eye Product Portfolio in the U.S.A.
05 nov. 2021 11h00 HE
|
I-MED Pharma
MONTREAL, Nov. 05, 2021 (GLOBE NEWSWIRE) -- I-MED Pharma USA is bringing the world’s most innovative dry eye product portfolio to the U.S. market. Their uniquely formulated line of ocular surface...